Infection of implanted material;Implantatinfektionen,-infektionen von implantiertem medizinischem Fremdmaterial

Chemotherapie Journal

Volumn 18, Issue 2, 2009, Pages 56-60

  Presterl, Elisabeth ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Biofilm; Implant infection; Resistance; Staphylococcus

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFAMANDOLE; CEFAZOLIN; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; DAPTOMYCIN; EXOPOLYSACCHARIDE; FOSFOMYCIN; LINEZOLID; OXACILLIN; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIUM ADHERENCE; BIOFILM; BONE INFECTION; BONE PROSTHESIS; CELL AGGREGATION; CORTICOSTEROID THERAPY; DEBRIDEMENT; HEALTH CARE COST; HEART VALVE PROSTHESIS; HUMAN; INFECTIOUS ARTHRITIS; JOINT PROSTHESIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSTEOMYELITIS; PACEMAKER; PROSTHESIS INFECTION; REVIEW; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 64549139770     PISSN: 09406735     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. von Eiff C, Jansen B, Kohnen W, Becker K. (2005). Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs 2005;65:179-214.
2. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-22.
3. von Eiff C, Peters G, Becker K. The small colony variant (SCV) concept - the role of staphylococcal SCVs in persistent infections. Injury 2006;37(Suppl 2):S26-33.
4. Ceri H, Olson ME, Stremick C, Read RR, et al. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999;37:1771-6.
5. Raad I, Hanna H, Jiang Y, Dvorak T, et al. Comparative activities of dap- tomycin, linezolid, and tigecycline against catheter-related methicillin- resistant Staphylococcus bacteremic isolates embedded in biofilm. Anti- microb Agents Chemother 2007;51:1656-60.
6. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004;350:1422-9.
7. Akowuah EF, Davies W, Oliver S, Stephens J, et al. Prosthetic valve endocarditis: early and late outcome following medical or surgical treatment. Heart 2003;89:269-72.
8. Sohail MR, Uslan DZ, Khan AH, Friedman PA, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007;45:166-73.
9. Da Costa A, Lelievre H, Kirkorian G, Celard M, et al. Role of the pre- axillary flora in pacemaker infections: a prospective study. Circulation 1998;97:1791-5.
10. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007;357:654-63.
11. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004;351:1645-54.
12. Zimmerli W, Widmer AF, Blatter M, Frei R, et al. Role of rifampicin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998;279;1537-41.
13. Svensson E, Hanberger H, Nilsson M, Nilsson LE. Factors affecting development of rifampicin resistance in biofilm-producing Staphylococcus epidermidis. J Antimicrob Chemother 1997;39:817-20.
14. Meehan AM, Osmon DR, Duffy MC, Hanssen AD, et al. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis 2003;36:845-9.
15. Presterl E, Grisold AJ, Reichmann S, Hirschl AM, et al. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics. J Antimicrob Chemother 2005;55:45-50.
16. Hoffmann N, Lee B, Hentzer M, Rasmussen TB, et al. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudo- monas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Antimicrob Agents Chemother 2007;51:3677-87.
17. Hansen CR, Pressler T, Koch C, Hoiby N. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study. J Cyst Fibros 2005;4:35-40.
18. Kandemir O, Oztuna V, Milcan A, Bayramoglu A, et al. Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis. Clin Orthop Relat Res 2005;(430):171-5.
19. Marchese A, Bozzolasco M, Gualco L, Debbia EA, et al. Effect of fosfomy- cin alone and in combination with N-acetylcysteine on E. coli biofifms. Int J Antimicrob Agents 2003;22(Suppl 2):95-100.
20. Liang X, Wang A, Cao T, Tang H, et al. Effect of cast molded rifampi- cin/silicone on Staphylococcus epidermidis biofilm formation. J Biomed Mater Res A 2006;76:580-8.
21. Gottlieb T, Mitchell D. The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR). J Antimicrob Chemother 1998;42:67-73.
22. Joukhadar C, Klein N, Dittrich P, Zeitlinger M, et al. Target site penetration of fosfomycin in critically ill patients. J Antimicrob Chemother 2003;51:1247-52.
23. Frossard M, Joukhadar C, Erovic BM, Dittrich P, et al. Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. Antimicrob Agents Chemother 2000;44:2728-32.
24. Raad I, Hanna H, Dvorak T, Chaiban G, et al. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother 2007;51:78-83.
25. Presterl E, Suchomel M, Eder M, Reichmann S, et al. Effects of alcohols, povidone-iodine and hydrogen peroxide on biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 2007;60:417-20.
26. Miller RR, Cappola AR, Shardell MD, Hawkes WG, et al. Persistent changes in interleukin-6 and lower extremity function following hip fracture. J Gerontol A Biol Sci Med Sci 2006;61:1053-8.
27. Donelli G, Francolini I, Romoli D, Guaglianone E, et al. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 2007;51:2733-40.
28. Balaban N, Giacometti A, Cirioni O, Gov Y, et al. Use of the quorum- sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J Infect Dis 2003;187:625-30.
29. Carmen JC, Roeder BL, Nelson JL, Ogilvie RL, et al. Treatment of biofilm infections on implants with low-frequency ultrasound and antibiotics. Am J Infect Control 2005;33:78-82.